Evidence map›Paper›PMID 34306162›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2021

Interstitial Cells of Cajal: Potential Targets for Functional Dyspepsia Treatment Using Medicinal Natural Products.

Jin-Yong Joung, Seo-Hyung Choi, Chang-Gue Son

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Combinatorial chemistry & high throughput screening · 2026
    Article
  2. Article
  3. Journal of microbiology and biotechnology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jin-Yong JoungLiver and Immunology Research Center, Oriental Medical College of Daejeon University, 75, Daedeok-daero 176 beon-gil, Seo-gu, Daejeon 35235, Republic of Korea.ORCID https://orcid.org/0000-0002-9814-7048
Seo-Hyung ChoiDepartment of Internal Medicine, Weedahm Oriental Hospital, 430, Yeoksam-ro, Gangnam-gu, Seoul 06200, Republic of Korea.ORCID https://orcid.org/0000-0002-6939-5085
Chang-Gue SonLiver and Immunology Research Center, Oriental Medical College of Daejeon University, 75, Daedeok-daero 176 beon-gil, Seo-gu, Daejeon 35235, Republic of Korea.ORCID https://orcid.org/0000-0003-4876-0167
Daejeon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe pathophysiology of functional dyspepsia (FD) remains uncertain, but the interstitial cells of Cajal (ICCs), pacemakers that regulate gastrointestinal motility, are garnering attention as key modulators and therapeutic targets in FD. This review comprehensively discusses the involvement of ICCs in the pharmacologic actions of FD and as therapeutic targets for herbal products for FD.

methodsA search of the literature was performed using PubMed by pairing "interstitial cells of Cajal" with "medicinal plant, herbal medicine, phytotherapy, flavonoids, or traditional Chinese medicine (TCM)."

resultsFrom the 55 articles screened in the initial survey, 34 articles met our study criteria. The search results showed that herbal products can directly depolarize ICCs to generate pacemaker potentials and increase the expression of c-kit and stem cell factors, helping to repair ICCs. Under certain pathological conditions, medicinal plants also protect ICCs from oxidative stress and/or inflammation-induced impairment. Two representative herbal decoctions (

conclusionThis review strongly indicates the potential of herbal products to target ICCs and suggests that further ICC-based studies would be promising for the development of FD treatment agents.

Identifiers

PMID34306162
PMCPMC8263244
OpenAlexW3173648022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.